Hatori M, Tsuji D, Suzuki K, Yokokawa T, Kawakami K, Moriyama R, Osada-Tsuchiya M, Otaki A, Nakao M, Yano T, Arakawa Y, Matsuo K, Ohashi Y, Sakata Y, Kogure Y, Tamaki S, Wada A, Taki Y, Sasahira N, Ishii H, Yamaguchi M, Itoh K.
Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study)

Cancer. in press

Uehara S, Hirai K, Shirai T, Itoh K.
Association of a CYP3A5 gene polymorphism with exacerbation in adult patients with asthma

J Allergy Clin Immunol Pract. in press

Hirai K, Kimura T, Suzuki Y, Shimoshikiryo T, Shirai T, Itoh K.
Gene Polymorphisms of NLRP3 Associated With Plasma Levels of 4β-Hydroxycholesterol, an Endogenous Marker of CYP3A Activity, in Patients With Asthma

Clin Pharmacol Ther. in press

Murofushi T, Yagi T, Tsuji D, Furushima D, Itoh K, Kawakami J.
Changes in estimated glomerular filtration rate in patients administered proton pump inhibitors: a single-center cohort study

Naunyn Schmiedebergs Arch Pharmacol. in press

Tsuji D, Nakagaki S, Yonezawa I, Suzuki K, Yokokawa T, Kawasaki Y, Yamaguchi T, Kawaguchi T, Hatori M, Matsumoto T, Sakata Y, Yamamoto K, Nishimura T, Kogure Y, Hayashi T, Osawa M, Itoh K, Watanabe M.
A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I

Invest New Drugs. 42:44-52 (2024)

Yokokawa T, Suzuki K, Tsuji D, Hosonaga M, Kobayashi K, Kawakami K, Kawazoe H, Nakamura T, Suzuki W, Sugisaki T, Aoyama T, Hashimoto K, Hatori M, Tomomatsu T, Inoue A, Azuma K, Asano M, Takano T, Ohno S, Yamaguchi M.
Influence of menopause on chemotherapy-induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study

Cancer Med. 12:18745-18754 (2023)

Miyagi T, Tsuji D, Kawasakai Y, Ishikawa H, Tanaka R, Nakao M, Nakagaki S, Hayashi T, Ayuhara H, Harada T, Tamaki S, Maeda A, Ohashi Y, Arakawa Y, Fujita Y, Yamamoto K, Miyamoto Y, Yano T, Itoh K.
Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer

Eur J Clin Pharmacol. 79:407-414 (2023)

Tamura K, Shirai T, Hirai K, Nakayasu H, Takahashi S, Kishimoto Y, Akamatsu T, Asada K, Kato S.
Mucus Plugs and Small Airway Dysfunction in Asthma, COPD, and Asthma-COPD Overlap

Allergy Asthma Immunol Res. 14:196-209 (2022)

Takahashi S, Shirai T, Hirai K, Akamatsu T.
Forced oscillatory parameters as predictors of COPD assessment test improvement in untreated COPD patients

Respir Physiol Neurobiol. 296:103809 (2022)

Watanabe H, Shirai T, Hirai K, Akamatsu T, Nakayasu H, Tamura K, Masuda T, Takahashi S, Tanaka Y, Kishimoto Y, Oishi K, Saigusa M, Yamamoto A, Morita S, Asada K.
Blood eosinophil count and FeNO to predict benralizumab effectiveness in real-life severe asthma patients

J Asthma. in press (2022)

Hirai K, Uehara S, Shirai T, Rachi Y, Kimura T, Akamatsu T, Itoh K.
Benralizumab restores gene and microRNA expression involved in steroid sensitivity in severe asthma

Allergy. 76:2589-2592 (2021)

Tsuji D, Saito Y, Mushiroda T, Miura M, Hira D, Terada T.
Results of a nationwide survey of Japanese pharmacists regarding the application of pharmacogenomic testing in precision medicine

J Clin Pharm Ther. 46:649-657 (2021)

Hirai K, Shirai T, Shimoshikiryo T, Ueda M, Gon Y, Maruoka S, Itoh K.
Circulating microRNA‐15b‐5p as a biomarker for asthma‐COPD overlap

Allergy. 76:766-774 (2021)

Suzuki K, Naito T, Tanaka H, Shibata K, Yamada Y, Itoh K, Kawakami J.
Impact of CYP2D6 activity and cachexia progression on enantiomeric alteration of plasma tramadol and its demethylated metabolites and their relationships with central nervous system symptoms in head and neck cancer patients

Basic Clin Pharmacol Toxicol. 128:472-481 (2021)

Tsuji D, Matsumoto M, Kawasaki Y, Kim YL, Yamamoto K, Nakamichi H, Sahara Y, Makuta R, Yokoi M, Miyagi T, Itoh K.
Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy

Cancer Chemother Pharmacol. 87:73-83 (2021)

Endo Y, Shirai T, Hirai K, Akamatsu T, Kato E, Furui H, Hiramatsu T.
High fractional exhaled nitric oxide levels may predict short-term worsening of respiratory oscillometry in asthma

Allergy. 76:363-366 (2021)

Shirai T, Hirai K, Gon Y, Maruoka S, Mizumura K, Hikichi M, Itoh K, Hashimoto S.
Combined assessment of serum eosinophil-derived neurotoxin and YKL-40 may identify Asthma-COPD overlap

Allergol Int. 70:136-139 (2021)

Yamamoto A, Shirai T, Hirai K, Tanaka Y, Watanabe H, Endo Y, Shimoda Y, Suzuki T, Noguchi R, Mochizuki E, Sakurai S, Saigusa M, Akamatsu T, Shishido Y, Akita T, Morita S, Asada K.
Oscillometry as a Predictor of Exercise Tolerance in COPD

COPD. 17:647-654 (2020)

Nishida S, Hayashi Y, Hirai K, Takekoshi A, Yamada Y, Kobayashi R, Shimizu S, Niwa T, Hayashi H, Shimohata T, Sugiyama T, Suzuki A.
Effect of therapeutic plasma exchange on phenytoin plasma concentration in patients receiving intravenous fosphenytoin therapy

Pharmazie. 75:488-490 (2020)

Oishi K, Matsunaga K, Shirai T, Hirai K, Gon Y.
Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease

J Clin Med. 9:2670 (2020)

Nomura H, Tsuji D, Demachi K, Mochizuki N, Matsuzawa H, Yano T, Daiko H, Fujii S, Kojima T, Itoh K, Kawasaki T.
ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel cisplatin and 5-fluorouracil chemotherapy

Cancer Chemother Pharmacol. 86:315-324 (2020)

Tanaka Y, Hirai K, Nakayasu H, Tamura K, Masuda T, Takahashi S, Watanabe H, Kishimoto Y, Ohishi K, Saigusa M, Akamatsu T, Yamamoto A, Morita S, Asada K, Shirai T.
Annual changes in forced oscillation technique parameters correlate with FEV1 decline in patients with asthma, COPD, and asthma-COPD overlap

Allergol Int. 69:626-627 (2020)

Shirai T, Akamatsu T, Hirai K, Watanabe H, Tamura K, Kishimoto Y, Saigusa M.
Oscillometry improves earlier than spirometry after benralizumab initiation in severe asthma

Allergy. 75:2678-2680 (2020)

Eliasen A, Dalhoff K, Mathiasen R, Schmiegelow K, Rechnitzer C, Schelde AB, Perwitasari DA, Tsuji D, Brok J.
Pharmacogenetics of antiemetics for chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis

Crit Rev Oncol Hematol. 149:102939 (2020)

Takeuchi M, Kobayashi T, Biss T, Kamali F, Vear SI, Ho RH, Bajolle F, Loriot MA, Shaw K, Carleton BC, Hamberg AK, Wadelius M, Hirono K, Taguchi M, Wakamiya T, Yanagimachi M, Hirai K, Itoh K, Brandao LR, Ito S.
CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis

Pharmacogenomics J. 20:306-319 (2020)

Suzuki K, Naito T, Tanaka H, Yamada Y, Itoh K, Kawakami J.
A reversed-phase mode LC-MS/MS method using a polysaccharide chiral selector for simultaneous quantitation of each enantiomer of tramadol and its metabolites in human plasma and evaluation of CYP-mediated stereoselective demethylation

Ther Drug Monit. 42:503-511 (2020)

Hirai K, Shirai T, Suzuki Y, Shimomura T, Itoh K.
Comparison of the association between circulating vitamin D3 levels and clinical outcomes in patients with asthma and chronic obstructive pulmonary disease: a prospective observational study

Biol Pharm Bull. 42:1861-1866 (2019)

Hirai K, Shirai T, Rachi Y, Uehara S, Ueda M, Nakatani E, Itoh K.
Impact of gene expression associated with glucocorticoid-induced transcript 1 (GLCCI1) on severe asthma and future exacerbation

Biol Pharm Bull. 42:1746-1752 (2019)

Shirai T, Hirai K, Gon Y, Maruoka S, Mizumura K, Hikichi M, Itoh K, Hashimoto S.
Forced Oscillation Technique May Identify Severe Asthma

J Allergy Clin Immunol Pract. 7:2857-2860 (2019)

Yamada T, Saito T, Shimizu Y, Tsukakoshi K, Hayashi H, Mizuno H, Tsuji D, Yamamoto K, Itoh K, Toyo'oka T, Ikebukuro K, Todoroki K.
Anti-Idiotype DNA Aptamer Affinity Purification High-Temperature Reversed-Phase Liquid Chromatography: A Simple, Accurate, and Selective Bioanalysis of Bevacizumab

Molecules. 24:857 (2019)

Yamamoto K, Sasano T, Tsuji D, Ishizuka Y, Tokou U, Nakamichi H, Yoneda T, Shiokawa M, Yabe K.
A Retrospective Analysis of the Effects of Chemotherapy-Induced Neutropenia on Overall Survival in Patients With Unresectable or Metastatic Urothelial Carcinoma to Gemcitabine Plus Cisplatin Combination Chemotherapy

Ann Pharmacother. 53:690-696 (2019)

Shirai T, Hirai K, Gon Y, Maruoka S, Mizumura K, Hikichi M, Itoh K, Hashimoto S.
Forced oscillation technique may identify asthma-COPD overlap

Allergol Int. 68:385-387 (2019)

Suzuki T, Shirai T, Hirai K, Tanaka Y, Watanabe H, Endo Y, Shimoda Y, Saigusa M, Akamatsu T, Yamamoto A, Morita S, Asada K.
Improved cough- and sputum-related quality of life after initiation of treatment in pulmonary tuberculosis

Respir Investig. 57:252-259 (2019)

Tsuji D, Suzuki K, Kawasaki Y, Goto K, Matsui R, Seki N, Hashimoto H, Hama T, Yamanaka T, Yamamoto N, Itoh K.
Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial

Support Care Cancer. 27:1139-1147 (2019)

Watanabe H, Shirai T, Akamatsu T, Asada K, Hirai K.
Forced oscillatory parameters in reversibility testing as predictors for chronic cough responsive to inhaled corticosteroid/long-acting β2 agonist

Ann Allergy Asthma Immunol. 122:345-346 (2019)

Shirai T, Hirai K, Gon Y, Maruoka S, Mizumura K, Hikichi M, Holweg C, Itoh K, Inoue H, Hashimoto S.
Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap

J Allergy Clin Immunol Pract. 7:134-145.e1 (2019)

Danese E, Raimondi S, Montagnana M, Tagetti A, Langaee T, Borgiani P, Ciccacci C, Carcas AJ, Borobia AM, Tong HY, Davila-Fajardo C, Botton MR, Bourgeois S, Deloukas P, Caldwell MD, Burmester JK, Berg RL, Cavallari LH, Drozda K, Huang M, Zhao LZ, Cen HJ, Gonzalez-Conejero R, Roldan V, Nakamura Y, Mushiroda T, Gong IY, Kim RB, Hirai K, Itoh K, Isaza C, Beltran L, Jimenez-Varo E, Canadas-Garre M, Giontella A, Kringen MK, Bente Foss Haug K, Gwak HS, Lee KE, Minuz P, Lee MTM, Lubitz SA, Scott S, Mazzaccara C, Sacchetti L, Genc E, Ozer M, Pathare A, Krishnamoorthy R, Paldi A, Siguret V, Loriot MA, Kutala VK, Suarez-Kurtz G, Perini J, Denny JC, Ramirez AH, Mittal B, Rathore SS, Sagreiya H, Altman R, Shahin MHA, Khalifa SI, Limdi NA, Rivers C, Shendre A, Dillon C, Suriapranata IM, Zhou HH, Tan SL, Tatarunas V, Lesauskaite V, Zhang Y, Maitland-van der Zee AH, Verhoef TI, de Boer A, Taljaard M, Zambon CF, Pengo V, Zhang JE, Pirmohamed M, Johnson JA, Fava C.
The effect of CYP4F2, VKORC1 and CYP2C9 in influencing coumarin dose. A single patient data meta-analysis in more than 15,000 individuals

Clin Pharmacol Ther. 105:1477-1491 (2019)

Shimizu H, Suzuki K, Uchikura T, Tsuji D, Yamanaka T, Hashimoto H, Goto K, Matsui R, Seki N, Shimada T, Ikeda S, Ikegami N, Hama T, Yamamoto N, Sasaki T.
Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)

J Pharm Health Care Sci. 4:31 (2018)

Ishii H, Hirai K, Sugiyama K, Nakatani E, Kimura M, Itoh K.
Validation of a nomogram for achieving target trough concentration of vancomycin: accuracy in patients with augmented renal function

Ther Drug Monit. 40:693-698 (2018)

Ohno Y, Niwa T, Hirai K, Suzuki K, Yamada Y, Hayashi Y, Hayashi H, Suzuki A, Itoh Y.
Time-Dependent Decline in Serum Phenytoin Concentration with Heightened Convulsive Seizure Risk by Prolonged Administration of Fosphenytoin in Japanese: A Retrospective Study

Ther Drug Monit. 40:507-511 (2018)

Hirai K, Shirai T, Suzuki M, Shimomura T, Itoh K.
Association between (CCTTT)n repeat polymorphism in NOS2 promoter and asthma exacerbations

J Allergy Clin Immunol. 142:663-665.e3 (2018)

Yokoi M, Tsuji D, Suzuki K, Kawasaki Y, Nakao M, Ayuhara H, Kogure Y, Shibata K, Hayashi T, Hirai K, Inoue K, Hama T, Takeda K, Nishio M, Itoh K.
Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy

Support Care Cancer. 26:1505-1513 (2018)

Egami Y, Narushima Y, Ohshima M, Yoshida A, Yoneta N, Masaki Y, Itoh K.
Human recombinant Fab fragment from combinatorial libraries of a B-cell lymphoma patient recognizes core protein of chondroitin sulfate proteoglycan 4

Journal of Biochemistry. 163:61-68 (2018)

Hirai K, Shirai T, Suzuki M, Akamatsu T, Suzuki T, Hayashi I, Yamamoto A, Akita T, Morita S, Asada K, Tsuji D, Inoue K, Itoh K.
A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype

Clin Exp Allergy. 47:1374-1382 (2017)

Otake A, Tsuji D, Taku K, Kawasaki Y, Yokoi M, Nakamori H, Osada M, Matsumoto M, Inoue K, Hirai K, Itoh K.
Chemotherapy-induced neutropenia as a prognostic factor in patients with metastatic pancreatic cancer treated with gemcitabine

Eur J Clin Pharmacol. 73:1033-1039 (2017)

Tsuji D, Yokoi M, Suzuki K, Daimon T, Nakao M, Ayuhara H, Kogure Y, Shibata K, Hayashi T, Hirai K, Inoue K, Hama T, Takeda K, Nishio M, Itoh K.
Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study

Pharmacogenomics J. 17:435-440 (2017)

Tsuji D, Ikeda M, Yamamoto K, Nakamori H, Kim Y, Kawasaki Y, Otaki A, Yokoi M, Inoue K, Hirai K, Nakamichi H, Tokou U, Shiokawa M, Itoh K.
Drug-related genetic polymorphisms affecting severe chemotherapy-induced neutropenia in breast cancer patients: A hospital-based observational study

Medicine. 95:e5151 (2016)

Hirai K, Ishii H, Shimoshikiryo T, Shimomura T, Tsuji D, Inoue K, Kadoiri T, Itoh K.
Augmented renal clearance in patients with febrile neutropenia is associated with increased risk for subtherapeutic concentrations of vancomycin

Ther Drug Monit. 38:706-710 (2016)

Hirai K, Shimomura T, Moriwaki H, Ishii H, Shimoshikiryo T, Tsuji D, Inoue K, Kadoiri T, Itoh K.
Risk factors for hypernatremia in patients with short- and long-term tolvaptan treatment

Eur J Clin Pharmacol. 72:1177-1183 (2016)

Inoue K, Murofushi T, Nagaoka K, Ando N, Hakamata Y, Suzuki A, Umemura A, Yoshida Y, Hirai K, Tsuji D, Itoh K.
Influence of genetic polymorphisms and concomitant anxiolytic doses on antidepressant maintenance doses in Japanese patients with depression

Biol Pharm Bull. 39:1508-1513 (2016)

Todoroki K, Nakano T, Eda Y, Ohyama K, Hayashi H, Tsuji D, Min JZ, Inoue K, Iwamoto N, Kawakami A, Ueki Y, Itoh K, Toyo'oka T.
Bioanalysis of bevacizumab and infliximab by high-temperature reversed-phase liquid chromatography with fluorescence detection after immunoaffinity magnetic purification

Anal Chim Acta. 916:112-119 (2016)

Inoue K, Yamamoto Y, Suzuki E, Takahashi T, Umemura A, Takahashi Y, Imai K, Inoue Y, Hirai K, Tsuji D, Itoh K.
Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy

Eur J Clin Pharmacol. 72:555-562 (2016)

Hirai K, Ihara S, Kinae A, Ikegaya K, Suzuki M, Hirano K, Itoh K.
Augmented renal clearance in pediatric patients with febrile neutropenia associated with vancomycin clearance

Ther Drug Monit. 38:393-397 (2016)

Mishima E, Jinno D, Akiyama Y, Itoh K, Nankumo S, Shima H, Kikuchi K, Takeuchi Y, Elkordy A, Suzuki T, Niizuma K, Ito S, Tomioka Y, Abe T.

Immuno-Northern Blotting: Detection of RNA Modifications by Using Antibodies against Modified Nucleosides

PLoS ONE, 10, e0143756 (2015)

Inoue K, Takahashi T, Yamamoto Y, Suzuki E, Takahashi Y, Imai K, Inoue Y, Hirai K, Tsuji D, Itoh K.

Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy

Seizure, 33, 76-80 (2015)

Hirai K, Yamada Y, Hayashi H, Tanaka M, Izumiya K, Suzuki M, Yoshizawa M, Moriwaki H, Akimoto T, Tsuji D, Inoue K, Itoh K.

Plasma vitamin K concentrations depend on CYP4F2 polymorphism and influence on anticoagulation in Japanese patients with warfarin therapy

Thromb Res, 135, 861-866 (2015)

Tazoe Y, Hayashi H, Tsuboi S, Shioura T, Matsuyama T, Yamada H, Hirai K, Tsuji D, Inoue K, Sugiyama T, Itoh K.

Reduced folate carrier 1 gene expression levels are correlated with methotrexate efficacy in Japanese patients with rheumatoid arthritis

Drug Metab Pharmacokinet. 30, 227-230 (2015)

Ikeda M, Tsuji D, Yamamoto K, Kim Y, Daimon T, Iwabe Y, Hatori M, Makuta R, Hayashi H, Inoue K, Nakamichi H, Shiokawa M, Itoh K.

Relationship between ABCB1 gene polymorphisms and severe neutropenia in patients with breast cancer treated with doxorubicin/cyclophosphamide chemotherapy

Drug Metab Pharmacokinet, 30, 149-153 (2015)

Tsuji D, Kamezato M, Daimon T, Taku K, Hatori M, Ikeda M, Hayashi H, Inoue K, Eto T, Itoh K.

Retrospective Analysis of Severe Neutropenia in Patients Receiving Concomitant Administration of Docetaxel and Clarithromycin

Chemotherapy, 59, 407-413 (2013)

Inoue K, Suzuki E, Takahashi T, Yamamoto Y, Yazawa R, Imai K, Miyakawa K, Inoue Y, Tuji D, Hayashi H, Itoh K.

4217C>A polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy

Epilepsy Res., 108, 1046-1051 (2014)

Mishima E, Inoue C, Saigusa D, Inoue R, Ito K, Suzuki Y, Jinno D, Tsukui Y, Akamatsu Y, Araki M, Araki K, Shimizu R, Shinke H, Suzuki T, Takeuchi Y, Shima H, Akiyama Y, Toyohara T, Suzuki C, Saiki Y, Tominaga T, Miyagi S, Kawagisihi N10, Soga T, Ohkubo T, Yamamura K, Imai Y1, Masuda S, Sabbisetti V, Ichimura T, Mount DB, Bonventre JV, Ito S, Tomioka Y, Itoh K, Abe T.

Conformational Change in Transfer RNA Is an Early Indicator of Acute Cellular Damage

J Am Soc Nephrol., 25, 2316-2326 (2014)

Yokoyama Y, Osano A, Hayashi H, Itoh K, Okura T, Deguchi Y, Ito Y, Yamada S

Endothelin-1 Receptors in Rat Tissues: Characterization by Bosentan, Ambrisentan and CI-1020

Biol. Pharm. Bull., 37, 461-4651 (2014)

Saito M, Kondo M, Ohshima M, Deguchi K, Hayashi H, Inoue K, Tsuji D, Masuko T, Itoh K.

Identification of anti-CD98 antibody mimotopes for inducing antibodies with antitumor activity by mimotope immunization

Cancer Sci., 105, 396-401 (2014)

Osano A, Yokoyama Y, Hayashi H, Itoh K, Okura T, Deguchi Y, Ito Y, Yamada S.

Bladder Endothelin-1 Receptor Binding of Bosentan and Ambrisentan

J. Pharmacol. Sci., 124, 86-91 (2014)

Inoue K, Suzuki E, Yazawa R, Yamamoto Y, Takahashi T, Takahashi Y, Imai K, Koyama S, Inoue Y, Tsuji D, Hayashi H, Itoh K.
Influence of Uridine Diphosphate Glucuronosyltransferase 2B7 -161C>T Polymorphism on the Concentration of Valproic Acid in Pediatric Epilepsy Patients

Ther. Drug Monit.,36, 406-409 (2014)

Yokoyama Y, Tomatsuri M, Hayashi H, Hirai K, Ono Y, Yamada Y, Todoroki K, Toyo'oka T, Yamada H, Itoh K.

Simultaneous microdetermination of bosentan, ambrisentan, sildenafil, and tadalafil in plasma using liquid chromatography/tandem mass spectrometry for pediatric patients with pulmonary arterial hypertension

J. Pharm. Biomed. Anal., 89, 227-232 (2014)

Tsuji D, Kim YI, Nakamichi H, Daimon T, Suwa K, Iwabe Y, Hayashi H, Inoue K, Yoshida M, Itoh K.

Association of ABCB1 polymorphisms with the antiemetic efficacy of granisetron plus dexamethasone in breast cancer patients

Drug Metab. Pharmacokinrt. 28, 299-304 (2013)

Hayashi H, Tazoe Y, Tsuboi S, Horino M, Morishita M, Arai T, Ohshima M, Matsuyama T, Kosuge K, Yamada H, Tsuji D, Inoue K, Itoh K.

A single nucleotide polymorphism of reduced folate carrier 1 predicts methotrexate efficacy in Japanese patients with rheumatoid arthritis

Drug Metab. Pharmacokinrt., 28, 164-168 (2013)

Hirai K, Hayashi H, Ono Y, Izumiya K, Tanaka M, Suzuki T, Sakamoto T, Itoh K.

Influence of CYP4F2 polymorphisms and plasma vitamin K levels on warfarin sensitivity in Japanese pediatric patients

Drug Metab. Pharmacokinrt., 28, 132-137 (2013)

Fujii S, Hayashi H, Itoh K, Yamada S, Deguchi Y, Kawazu K.

Characterization of the carrier-mediated transport of ketoprofen, a nonsteroidal anti-inflammatory drug, in rabbit corneal epithelium cells

J. Pharm. Pharmacol., 65, 171-180 (2013)

Yamamoto Y, Takahashi Y, Imai K, Mishima N, Yazawa R, Inoue K, Itoh K, Kagawa Y, Inoue Y.

Risk factors for hyperammonemia in pediatric patients with epilepsy

Epilepsia, 54, 983-989 (2013)

Inoue K, Sonobe M, Kawamura Y, Etoh T, Takagi M, Matsumura T, Kikuyama M, Kimura M, Minami S, Utsuki H, Yamazaki T, Suzuki T, Tsuji D, Hayashi H, Itoh K.

Polymorphisms of the UDP-glucuronosyl transferase 1A genes are associated with adverse events in cancer patients receiving irinotecan-based chemotherapy

Tohoku J. Exp. Med., 229, 107-114 (2013)

Nakamichi H, Fujita T, Tsuji D, Atsumi I, Totsuka K, Suzuki R, Miki Y, Tomita K, Nakamura H, Shiokawa M.

Analysis of risk factors of drug-induced lung injury in patients receiving gemcitabine treatment

Gan To Kagaku Ryoho, 39, 787-792 (2012)

Yamamoto Y, Takahashi Y, Suzuki E, Mishima N, Inoue K, Itoh K, Kagawa Y, Inoue Y.

Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients

Epilepsy Res., 101, 202-9 (2012)

Inoue K, Ando N, Suzuki E, Hayashi H, Tsuji D, Itoh K.

Genotype distributions and allele frequencies of possible major depressive disorder-associated single nucleotide polymorphisms, cyclic adenosine monophosphate response element binding protein 1 rs4675690 and Piccolo rs2522833, in a Japanese population

Biol. Pharm. Bull., 35, 265-268 (2012)

Tsuji D, Kim YI, Taku K, Nakagaki S, Ikematsu Y, Tsubota H, Maeda M, Hashimoto N, Kimura M, Daimon T.

Comparative trial of two intravenous doses of granisetron (1 versus 3 mg) in the prevention of chemotherapy-induced acute emesis: a double-blind, randomized, non-inferiority trial

Support Care Cancer, 20, 1057-1064 (2012)

Hayashi H, Tazoe Y, Horino M, Fujimaki-Katoh C, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, Tsuji D, Inoue K, Itoh K.

An artifact derived from pseudogene led to the discovery of micro RNA binding site polymorphism in 3′-untranslated region of human dihydrofolate reductase gene

Drug Metab. Pharmacokinet., 27, 263-267 (2012)

Yoshida A, Hirooka Y, Sugata Y, Nitta M, Manabe T, Ido S, Murakami K, Saha RK, Suzuki T, Ohshima M, Yoshida A, Itoh K, Shimizu K, Oku N, Furuta T, Asakawa T, Wakimoto T, Kan T

Concise synthesis of catechin probes enabling analysis and imaging of EGCg

Chem. Commun., 47, 1794-1796 (2011)